Infectious Disease
Company awarded SIBR grant for infectious disease detection
Published in Medical Letter on the CDC and FDA, November 7th, 2004
This Phase I Grant will help fund research to develop highly specific recombinant antibodies to Clostridium difficile toxins A & B, and to use these unique antibodies to develop rapid, inexpensive and sensitive diagnostics.
Clostridium difficile infection is a serious medical problem affecting up to 3 million patients annually in the United States. Up to 20% of all hospital inpatients, 95 to 100% of those with pseudomembranous colitis, and 25 to 80% of all healthy neonates and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Brain Cancer
N-ethyl-N-nitrosourea increases brain mutations in neonatal mice - HIV/AIDS Therapy
Critical reporting elements for quality of study methods reported - Pneumococcal Vaccine
Murine model of immunity induced by pneumococcal vaccine developed - Poliomyelitis
Change in polio vaccine policy eliminates cases of vaccine-associated polio - West Nile Fever
Clinicopathologic study of West Nile Virus encephalomyelitis reported - AIDS/HIV Diagnosis
HIV-1 superinfections assessed by autologous heteroduplex mobility - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
